S F Lanes

Summary

Affiliation: Boehringer Ingelheim

Publications

  1. ncbi Biological interpretation of relative risk
    S F Lanes
    Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut 06877 0368, USA
    Drug Saf 21:75-9. 1999
  2. ncbi Respiratory medications and risk of asthma death
    S F Lanes
    Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877 0368, USA
    Thorax 57:683-6. 2002
  3. ncbi Bias due to false-positive diagnoses in an automated health insurance claims database
    Stephan F Lanes
    Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut 06877 0368, USA
    Drug Saf 29:1069-75. 2006
  4. ncbi Respiratory medications and the risk of cardiac arrhythmias
    Consuelo Huerta
    Centro Español de Investigación Farmacoepidemiológica, Almirante 28, 2o, 28004 Madrid, Spain
    Epidemiology 16:360-6. 2005
  5. ncbi Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark
    Cynthia de Luise
    Epidemiology, Pfizer Inc, 235 E 42nd Street, 150 3 80, New York, NY 10017, USA
    Eur J Epidemiol 22:267-72. 2007
  6. ncbi Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database
    Michele Jara
    Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877 0368, USA
    Drug Saf 30:1151-60. 2007
  7. ncbi The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids
    Stephan F Lanes
    Am J Respir Crit Care Med 178:543-4; author reply 544. 2008

Detail Information

Publications7

  1. ncbi Biological interpretation of relative risk
    S F Lanes
    Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut 06877 0368, USA
    Drug Saf 21:75-9. 1999
    ..Interpretation then becomes a more directed task, with a focus on the validity of certain ancillary hypotheses upon which biological interpretability rests...
  2. ncbi Respiratory medications and risk of asthma death
    S F Lanes
    Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877 0368, USA
    Thorax 57:683-6. 2002
    ..The effect of respiratory medications on risk of asthma death in the UK was studied using the General Practice Research Database...
  3. ncbi Bias due to false-positive diagnoses in an automated health insurance claims database
    Stephan F Lanes
    Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut 06877 0368, USA
    Drug Saf 29:1069-75. 2006
    ..To assess the reliability of automated data, we compared the hospitalisation and mortality rates among three similar studies of automated healthcare databases in North America...
  4. ncbi Respiratory medications and the risk of cardiac arrhythmias
    Consuelo Huerta
    Centro Español de Investigación Farmacoepidemiológica, Almirante 28, 2o, 28004 Madrid, Spain
    Epidemiology 16:360-6. 2005
    ..Most of these drugs have been associated indirectly with cardiac rhythm disorders, but epidemiologic evidence is limited...
  5. ncbi Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark
    Cynthia de Luise
    Epidemiology, Pfizer Inc, 235 E 42nd Street, 150 3 80, New York, NY 10017, USA
    Eur J Epidemiol 22:267-72. 2007
    ..An increase in COPD hospitalization is inconsistent with clinical trial data and suggests preferential prescribing due to disease severity...
  6. ncbi Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database
    Michele Jara
    Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877 0368, USA
    Drug Saf 30:1151-60. 2007
    ..In COPD, the organ system most frequently requiring medical care, other than the respiratory system, is the cardiac system...
  7. ncbi The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids
    Stephan F Lanes
    Am J Respir Crit Care Med 178:543-4; author reply 544. 2008